BLUE

bluebird bio
BLUE

Overview Fund Activity
Delisted

BLUE was delisted on the 30th of May, 2025.

Back to rankings

6 hedge funds and large institutions have $15.2M invested in bluebird bio in 2013 Q2 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
6
Holders Change
+6
Holders Change %
–
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Ameriprise
1
Ameriprise
Minnesota
$8.07M
2
CCM
2
Camber Capital Management
Massachusetts
$3.75M
3
Citadel Advisors
3
Citadel Advisors
Florida
$1.25M
4
MCM
4
Mazama Capital Management
Oregon
$749K
5
Alyeska Investment Group
5
Alyeska Investment Group
Illinois
$749K

Top Sellers

No sellers this quarter
Name Market Value Shares Shares
Change 		Shares
Change %
Ameriprise
1
Ameriprise
Minnesota
$8.07M 323,130 +323,130 New
CCM
2
Camber Capital Management
Massachusetts
$3.75M 150,000 +150,000 New
Citadel Advisors
3
Citadel Advisors
Florida
$1.25M 49,991 +49,991 New
MCM
4
Mazama Capital Management
Oregon
$749K 30,000 +30,000 New
Alyeska Investment Group
5
Alyeska Investment Group
Illinois
$749K 30,000 +30,000 New
EEG
6
E.E. Geduld
$643K 25,750 +25,750 New